MDM2 and cancer: RG7112 results in p53 accumulation and activation of p53 signaling in cancer cells that express wild-type p53, which has been shown to deplete MDM2-upregulated progenitor/stem cells and inhibit the growth of human tumor xenografts by causing cell cycle arrest and apoptosis [62,63].